Stock ScreenerStock IdeasFounder-Led CompaniesFounder-Led CompaniesA Bain & Co. study found that founder-led companies performed "3.1 times better" during the study period of 1999 to 2014
Stock ScreenerStock IdeasFounder-Led Companies
Ticker: AKAM + 110 more
| Ticker | Company | Performance Score | Market Cap | Revenue | EBITDA | Earnings | EPS | Revenue Growth Y/Y | Revenue Growth 5Y | Earnings Growth Y/Y | Earnings Growth 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTNX | NUTANIX INC | $15.96B | $2.02B | $61.81M | -$67.31M | -$0.29 | 18.12% | 10.21% | N/A | N/A | 2024-05-29 | |
| KKR | KKR & CO INC | $88.09B | $14.50B | $7.88B | $3.68B | $4.24 | 154.19% | 43.34% | N/A | 14.65% | ||
| IONS | IONIS PHARMACEUTICALS INC | $5.97B | $776.62M | -$254.76M | -$384.77M | -$2.67 | 34.84% | 0.63% | N/A | N/A | 2024-05-14 | |
| LPSN | LIVEPERSON INC | $52.16M | $401.98M | -$46.19M | -$100.44M | -$1.28 | -21.91% | 9.98% | N/A | N/A | 2024-05-08 | |
| BYND | BEYOND MEAT INC | $535.53M | $343.38M | -$277.95M | -$338.14M | -$5.26 | -18.04% | 31.32% | N/A | N/A | 2024-05-08 | |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | $3.49B | $442.59M | -$585.60M | -$613.35M | -$7.95 | 15.29% | 49.64% | N/A | N/A | 2024-06-18 | |
| RNG | RINGCENTRAL INC | $2.76B | $2.25B | $152.37M | -$139.34M | -$1.49 | 9.67% | 25.46% | N/A | N/A | ||
| MPW | MEDICAL PROPERTIES TRUST INC | $2.56B | $871.80M | $340.14M | -$556.48M | -$0.93 | -43.49% | 2.13% | N/A | N/A | 2024-05-09 | |
| TREE | LENDINGTREE INC | $647.08M | $639.76M | -$105.67M | -$134.85M | -$10.36 | -29.10% | -5.44% | N/A | N/A | ||
| W | WAYFAIR INC | $8.48B | $11.96B | -$186.00M | -$631.00M | -$5.35 | -0.34% | 10.31% | N/A | N/A | ||
| AIV | APARTMENT INVESTMENT & MANAGEMENT CO | $1.20B | $187.00M | -$72.40M | -$166.20M | -$1.16 | -1.76% | 7.19% | N/A | N/A | 2024-05-08 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.